Q51781159
0 sources
Q51781159
Summary
Q51781159 is a laboratory[1].
Key Facts
- Q51781159 is located in Clermont-Ferrand[2].
- Q51781159 is in the country of France[3].
- Q51781159's instance of is recorded as laboratory[4].
- +2012-01-01T00:00:00Z marks the founding of Q51781159[5].
- Q51781159's parent organization or unit is recorded as University of Auvergne - Clermont I[6].
- Q51781159's parent organization or unit is recorded as French National Institute of Health and Medical Research[7].
- Q51781159's parent organization or unit is recorded as Clermont-Ferrand University Hospital[8].
- Q51781159's parent organization or unit is recorded as Clermont Auvergne University[9].
- Q51781159's official website is recorded as http://www.u-clermont1.fr/neuro-dol.html[10].
- Q51781159's official website is recorded as https://neurodol.uca.fr/[11].
- Q51781159's short name is recorded as NEURO-DOL[12].
- Q51781159's GRID ID is recorded as grid.503334.2[13].
- Q51781159's French national research structure ID is recorded as 201220182P[14].
- Q51781159's street address is recorded as Facultés de Médecine/Pharmacie, 28 Place Henri-Dunant, BP 38[15].
- Q51781159's ROR ID is recorded as 028m9sy08[16].
- Q51781159's Scilit organization ID is recorded as 93013[17].
Body
Founding
+2012-01-01T00:00:00Z marks the founding of Q51781159[5].
Identity
Q51781159's short name is recorded as NEURO-DOL[12].
Operations
Parent organizations include University of Auvergne - Clermont I[6], a university in France[18], in France[19], founded in 1976[20], headquartered in Clermont-Ferrand[21]; French National Institute of Health and Medical Research[7], a French public establishment of a scientific and technological character[22], in France[23], founded in 1964[24], headquartered in Paris[25]; Clermont-Ferrand University Hospital[8], a hospital network[26], in France[27], headquartered in Clermont-Ferrand[28]; and Clermont Auvergne University[9], a university in France[29], in France[30], founded in 2017[31], headquartered in Clermont-Ferrand[32].